Angiotensin Receptor-Neprilysin Inhibition Therapy and Improved Exercise Parameters in Heart Failure with Reduced Ejection Fraction

被引：2
|
作者：
Schwartzmann, Pedro [1 ]
机构：
[1] Hosp Unimed Ribeirao Preto, Ribeirao Preto, SP, Brazil
来源：
ARQUIVOS BRASILEIROS DE CARDIOLOGIA | 2020年 / 115卷 / 05期
关键词：
Heart Failure; Stroke Volume; Fatigue; Mortality; Morbidity; Prognosis; Exercise; Intolerance;
D O I：
10.36660/abc.20200566
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：828 / 829
页数：2
相关论文
共 50 条
  • [21] Physician adherence and patient-reported outcomes in heart failure with reduced ejection fraction in the era of angiotensin receptor-neprilysin inhibitor therapy
    Kim, In-Cheol
    Youn, Jong-Chan
    Jang, Se Yong
    Lee, Sang Eun
    Cho, Hyun-Jai
    Choi, Jin-Oh
    Lee, Ju-Hee
    Kim, Kyung-Hee
    Lee, Sun Hwa
    Kim, Kye Hun
    Lee, Jong Min
    Yoo, Byung-Su
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [22] Effects of Angiotensin Receptor Neprilysin Inhibitor on Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction
    Tabl, Mohamed Abd E.
    Essawy, Tarek Samy
    JACC-CARDIOVASCULAR INTERVENTIONS, 2020, 13 (04) : S40 - S41
  • [23] Positive Recommendation for Angiotensin Receptor-Neprilysin Inhibitor: First Medication Approval for Heart Failure Without Reduced Ejection Fraction
    Howlett, Jonathan G.
    CANADIAN JOURNAL OF CARDIOLOGY, 2021, 37 (04) : 528 - 530
  • [24] Coronary Flow Reserve Changes after Angiotensin Receptor-Neprilysin Inhibitor Treatment in Heart Failure with Reduced Ejection Fraction
    Karaayvaz, Ekrem Bilal
    Guz, Goksel
    ACTA CARDIOLOGICA SINICA, 2023, 39 (06) : 871 - 878
  • [25] Effects of angiotensin receptor neprilysin inhibition on pulmonary arterial stiffness in heart failure with reduced ejection fraction
    Mustafa Yenerçağ
    Uğur Arslan
    Seçkin Dereli
    Metin Çoksevim
    Mustafa Doğduş
    Ahmet Kaya
    The International Journal of Cardiovascular Imaging, 2021, 37 : 165 - 173
  • [26] Effects of angiotensin receptor neprilysin inhibition on pulmonary arterial stiffness in heart failure with reduced ejection fraction
    Yenercag, Mustafa
    Arslan, Ugur
    Dereli, Seckin
    Coksevim, Metin
    Dogdus, Mustafa
    Kaya, Ahmet
    INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING, 2021, 37 (01): : 165 - 173
  • [27] Impact of angiotensin receptor-neprilysin inhibition (ARNI) in improving ejection fraction and left and right ventricular remodeling in heart failure
    Bhushan, Sandeep
    Huang, Xin
    Jiang, Fenglin
    Xiao, Zongwei
    CURRENT PROBLEMS IN CARDIOLOGY, 2024, 49 (04)
  • [28] Timing of angiotensin receptor-neprilysin inhibitor initiation in patients with heart failure and reduced ejection fraction: data from the Swedish heart failure registry
    Stolfo, D.
    Lund, L.
    Benson, L.
    Kack, O.
    Lindberg, F.
    Sinagra, G.
    Dahlstrom, U.
    Savarese, G.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [29] Six months clinical and echocardiographic outcome of angiotensin receptor-neprilysin inhibitor (sacubitril/valsartan) therapy in heart failure patients with reduced ejection fraction
    Alnims, M. Mohammed
    Magdy, Abdelhamid
    Meguid, M. Abdel
    Ahmed, Shehata
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 101 - 102
  • [30] FRAILTY AND UPTAKE OF ANGIOTENSIN RECEPTOR NEPRILYSIN INHIBITOR FOR HEART FAILURE WITH REDUCED EJECTION FRACTION
    Ko, Darae
    Lee, Yu-Chien
    Lin, Kueiyu Joshua
    Cheng, Susan
    Patorno, Elisabetta
    Glynn, Robert J.
    Tsacogianis, Theodore
    Kim, Dae Hyun
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 521 - 521
12345